The National Institute of Allergy and Infectious Diseases (NIAID), has awarded 12 institutes with grants towards phage therapy research.
Phico Therapeutics receives funding from CARB-X towards the development of engineered bacteriophage with SASP gene targeting Pseudomonas aeruginosa.
Synthetic bacteriophages with shortened genome created successfully by scientists from CEB – Centre of Biological Engineering, Braga in Portugal.
CBASS or the self-destruct mechanism is another immune mechanism that bacteria utilize against bacteriophage.
Bacteriophage preparation methodology for phage cocktails and products for treatment or prophylactic uses practiced in ex-Soviet countries.
Lysogeny is one of the two replication cycles that bacteriophages can undergo. This article looks into the discovery of lysogeny in the scientific community.